In models of focal cerebral ischemia, taurine was reported to inhibit the ischemia-induced activation of m-calpain (no significant effect was observed on μ-calpain) in a dose-dependent manner by enhancing the expression and activity of calpastatin. This evidence concerns the gene CAPN2 and ischemia.